口腔上皮异型增生分类共识:p53/p16免疫组化辅助诊断的对比分析
传统三级和二级分级系统的一致性较差(κ=0.32和0.39),而基于p53/p16免疫组化的p53野生型/p53异常/HPV相关分类一致性达到中等至良好(κ=0.59),提示该分类方法优于传统组织学分级。
要点
- 传统口腔上皮异型增生分级系统病理医生间一致性差。
- p53/p16免疫组化辅助的p53野生型/异常/HPV相关分类一致性中等至良好。
- 常规免疫组化可识别更广谱的HPV相关口腔上皮异型增生。
核心结论
- 基于p53/p16免疫组化的口腔上皮异型增生分类(p53野生型/p53异常/HPV相关)在病理医生间的一致性优于传统三级和二级分级系统。
- 常规使用免疫组化有助于识别更广泛组织学谱的HPV相关口腔上皮异型增生。
研究设计与样本
- 队列包括8例p53野生型、24例p53异常和18例HPV相关口腔上皮异型增生。
主要发现
- H&E三级分级系统的一致性差(κ=0.32)。
- H&E二级分级系统的一致性差(κ=0.39)。
- 结合免疫组化的p53野生型/p53异常/HPV相关分类一致性为中等至良好(κ=0.59)。
关键数值与推荐
- 传统三级分级系统κ=0.32。
- 传统二级分级系统κ=0.39。
- p53野生型/p53异常/HPV相关分类结合免疫组化κ=0.59。
临床怎么用
- 在口腔上皮异型增生诊断中可考虑常规使用p53/p16免疫组化辅助分类。
- 采用p53野生型/p53异常/HPV相关分类可能提高病理医生间诊断一致性。
局限性
- 该分类系统预测患者结局和指导管理决策的有效性尚需在真实世界队列中进一步研究。
- 队列富集了p53异常口腔上皮异型增生,可能影响结果的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diagnosis and classification of oral epithelial dysplasia (OED) is critical to identifying and prognosticating patients at risk of squamous cell carcinoma (SCC). However, conventional 3-tiered and 2-tiered grading systems suffer from poor inter-pathologist agreement, and SCC may arise from all grades of OED. This study evaluated pathologist agreement in OED classification as p53 wildtype, p53 abnormal, and HPV-associated based on recent evidence demonstrating the utility of p53/p16 immunohistochemistry (IHC) in this setting and increased risk of p53 abnormal OED progression to SCC, regardless of histologic grade. Fifty digital biopsy specimens were evaluated for diagnosis by 18 subspecialty-trained pathologists, with OED graded utilizing 3-tiered, 2-tiered, and p53 wildtype/p53 abnormal/HPV-associated schemata. Cases were reviewed first without and subsequently with p53/p16 IHC. The cohort consisted of 8 cases of p53 wildtype, 24 cases of p53 abnormal, and 18 cases of HPV-associated OED. Inter-pathologist agreement in OED grading according to 3-tiered (κ=0.32) and 2-tiered (κ=0.39) systems by H&E was poor, but fair-to-good (κ=0.59) in classification as p53 wildtype/p53 abnormal/HPV-associated by H&E and IHC. Classification of OED as p53 wildtype, p53 abnormal, or HPV-associated using p53/p16 IHC outperformed conventional grading in this cohort enriched for p53 abnormal OED, which required correct interpretation of p53 IHC, historically deemed challenging. Routine use of IHC also identifies a wider histologic spectrum of HPV-associated OED than is currently appreciated. More work is needed to determine the efficacy of this classification system in predicting patient outcomes and in guiding management decisions in real-world cohorts.
引用
- Stojanov IJ, Liu KYP, McCord C, et al. Consensus in Oral Epithelial Dysplasia Classification: A Comparative Analysis of H&E-stained Sections With and Without p53/p16 Immunohistochemistry. Am J Surg Pathol. 2025. PMID: 40202378. doi:10.1097/PAS.0000000000002385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。